🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of Tylenol, claiming the corporations hid safety concerns that the pain reliever presented to pediatric neurological development.

The lawsuit comes a month after President Donald Trump advocated an unverified association between consuming acetaminophen - referred to as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is filing suit against J&J, which previously sold the drug, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a official comment, he said they "misled consumers by making money from discomfort and marketing drugs without regard for the dangers."

The company says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking numerous people to line their pockets," the attorney general, a Republican, stated.

The company said in a statement that it was "very worried by the spread of false claims on the reliability of acetaminophen and the likely effects that could have on the welfare of women and children in America."

On its website, the company also stated it had "consistently assessed the pertinent research and there is no credible data that demonstrates a established connection between taking acetaminophen and autism."

Associations representing doctors and health professionals share this view.

The leading OB-GYN organization has said paracetamol - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to treat pain and elevated temperature, which can create significant medical dangers if left untreated.

"In over twenty years of studies on the use of paracetamol in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any period of pregnancy results in neurodevelopmental disorders in young ones," the association said.

This legal action references latest statements from the former administration in claiming the medication is potentially dangerous.

Last month, the former president raised alarms from public health officials when he instructed women during pregnancy to "resist strongly" not to use Tylenol when unwell.

The US Food and Drug Administration then issued a notice that medical professionals should contemplate reducing the use of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in young ones has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would determine the origin of autism in a limited time.

But experts cautioned that identifying a sole reason of autism - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and disability that affects how persons experience and engage with the environment, and is recognized using physician assessments.

In his lawsuit, Paxton - a Trump ally who is running for US Senate - claims Kenvue and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the companies "eliminate any marketing or advertising" that states Tylenol is reliable for pregnant women.

This legal action mirrors the grievances of a group of guardians of minors with autism spectrum disorder and ADHD who filed suit against the makers of Tylenol in two years ago.

A federal judge rejected the legal action, declaring investigations from the family's specialists was inconclusive.